Trabeculectomy Versus Canaloplasty (TVC)
Primary Purpose
Glaucoma, Canaloplasty, Trabeculectomy
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
trabeculectomy
Canaloplasty
Sponsored by
About this trial
This is an interventional treatment trial for Glaucoma focused on measuring trabeculectomy,, canaloplasty,, glaucoma surgery, non-penetrating surgery
Eligibility Criteria
Inclusion Criteria:1. diagnosed primary or secondary open-angle glaucoma 2. IOP > 16 mmHg (<60 days prior surgery) 3. IOP > 21 mmHg 4. no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed
Exclusion Criteria:
- angle closure glaucoma
- congenital glaucoma
- combined procedures (glaucoma and cataract)
Sites / Locations
- University Eye Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Trabeculectomy
Canaloplasty
Arm Description
Trabeculectomy with Mitomycin C
Canaloplasty with implant of suture
Outcomes
Primary Outcome Measures
success rate (complete and qualified success)
Success is defined 1. IOP < 21 mmHg and at least 20% IOP reduction from baseline 2. IOP < 18 mmHg
success rate (complete and qualified success)
Success is defined 1. IOP < 21 mmHg and at least 20% IOP reduction from baseline 2. IOP < 18 mmHg
Secondary Outcome Measures
IOP, medication, complications
intraocular pressure reduction, medication postoperatively, complications intra- and postoperatively
IOP, medication, complications
intraocular pressure reduction, medication postoperatively, complications intra- and postoperatively
Full Information
NCT ID
NCT01228799
First Posted
October 20, 2010
Last Updated
August 16, 2013
Sponsor
University Eye Hospital, Würzburg
1. Study Identification
Unique Protocol Identification Number
NCT01228799
Brief Title
Trabeculectomy Versus Canaloplasty
Acronym
TVC
Official Title
Longterm Comparison Between Trabeculectomy and Canaloplasty in Open-angle Glaucoma
Study Type
Interventional
2. Study Status
Record Verification Date
October 2010
Overall Recruitment Status
Completed
Study Start Date
June 2010 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
December 2012 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Eye Hospital, Würzburg
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Study aims for comparison of trabeculectomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically uncontrolled open-angle glaucoma. Canaloplasty is a recently newly introduced procedure, which showed encouraging results without antimetabolite usage intra- and postoperatively. Purpose of the study is to compare both surgeries concerning success rate, intraocular pressure, medication and complications. So far there is no comparison of the standard procedure trabeculectomy and the new approach, canaloplasty available.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glaucoma, Canaloplasty, Trabeculectomy
Keywords
trabeculectomy,, canaloplasty,, glaucoma surgery, non-penetrating surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
64 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Trabeculectomy
Arm Type
Active Comparator
Arm Description
Trabeculectomy with Mitomycin C
Arm Title
Canaloplasty
Arm Type
Active Comparator
Arm Description
Canaloplasty with implant of suture
Intervention Type
Procedure
Intervention Name(s)
trabeculectomy
Intervention Description
trabeculectomy with mitomycin C 0.2mg/ml
Intervention Type
Procedure
Intervention Name(s)
Canaloplasty
Intervention Description
Canaloplasty with implant of suture
Primary Outcome Measure Information:
Title
success rate (complete and qualified success)
Description
Success is defined 1. IOP < 21 mmHg and at least 20% IOP reduction from baseline 2. IOP < 18 mmHg
Time Frame
1 year
Title
success rate (complete and qualified success)
Description
Success is defined 1. IOP < 21 mmHg and at least 20% IOP reduction from baseline 2. IOP < 18 mmHg
Time Frame
2 years
Secondary Outcome Measure Information:
Title
IOP, medication, complications
Description
intraocular pressure reduction, medication postoperatively, complications intra- and postoperatively
Time Frame
1 year
Title
IOP, medication, complications
Description
intraocular pressure reduction, medication postoperatively, complications intra- and postoperatively
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:1. diagnosed primary or secondary open-angle glaucoma 2. IOP > 16 mmHg (<60 days prior surgery) 3. IOP > 21 mmHg 4. no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed
Exclusion Criteria:
angle closure glaucoma
congenital glaucoma
combined procedures (glaucoma and cataract)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Klink, MD
Organizational Affiliation
University Eye Hospital, Würzburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Eye Hospital
City
Würzburg
State/Province
Bavaria
ZIP/Postal Code
97080
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Trabeculectomy Versus Canaloplasty
We'll reach out to this number within 24 hrs